Researchers at Immunocore Limited today announced that IMCgp100, a targeted therapeutic for the treatment of advanced metastatic melanoma, has received regulatory and ethics approval and has opened enrolment for clinical trials in the England and USA. IMCgp100 is the first clinical candidate ... READ MORE
News for Cancer
Tumour mapping for novel cancer treatment in Oxford
Professor Mark Middleton, Professor John Bell, Dr Jenny Taylor and research colleagues from Oxford were interviewed on BBC Radio 4 on 17 February about new generations of cancer drugs. Discussions centred around advances in tumour mapping, patients' experiences, advances in genetic testing and ... READ MORE